Drug intelligence / Profile preview

Lizhong Fuyuanfang

Development stage: Preclinical
Lead developer: Shanghai Municipal Hospital of Traditional Chinese Medicine
Administration: Oral

Overview

Lizhong Fuyuanfang is a Traditional Chinese Medicine (TCM) formula currently being investigated for the treatment of chronic atrophic gastritis with weak spleen and stomach. It is a complex herbal preparation, likely a variation of the classic Lizhong Decoction, designed to restore and strengthen the functions of the spleen and stomach according to TCM principles.

Beyond the preview

Go deeper on Lizhong Fuyuanfang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lizhong Fuyuanfang.

Explore the full profile